SION CIK: 2036042

Sionna Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
151
FY25:
241
(positive)
Change from FY24 to FY25
millions USD
FY24:
34.8
FY25:
84.5
Total assets
Change from FY24 to FY25
millions USD
FY24:
186
FY25:
326

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
10.4
FY25:
11.7
(negative)
Change from FY24 to FY25
millions USD
FY24:
8.68
FY25:
7.41
(positive)
Change from FY24 to FY25
millions USD
FY24:
−164
FY25:
307
Total liabilities & equity
millions USD
FY24:
–
FY25:
326

All amounts in millions USD Data source:SEC EDGAR